Pricing Log in Create free account

Codexis, Inc. (CDXS) vs PDS Biotechnology Corporation (PDSB)

Codexis, Inc. and PDS Biotechnology Corporation are both Biotechnology companies. Codexis, Inc. and PDS Biotechnology Corporation are of similar size ($109.5M and $108.2M). PDS Biotechnology Corporation has the higher net margin (0.00% vs −39.6%) and the higher return on invested capital (0.00% vs −151.2%). Across the 13 metrics below, Codexis, Inc. leads on 7 and PDS Biotechnology Corporation on 6.

Valuation

Metric CDXS PDSB Biotechnology median
P/E n/m n/m 11.58
P/S 1.14 n/m 9.61
P/B 2.68 n/m 2.26
Price to free cash flow n/m n/m 26.41
EV/EBITDA n/m n/m 0.72
EV/Sales 0.86 n/m 9.43
Earnings yield (35.05%) (63.37%) (32.28%)
Free cash flow yield (13.77%) (29.42%) (22.27%)

Profitability

Metric CDXS PDSB Biotechnology median
Gross margin 87.02% 0.00% 68.81%
Operating margin (35.61%) 0.00% 0.00%
Net margin (39.55%) 0.00% 0.00%
Free cash flow margin (15.66%) 0.00% 0.00%
Return on equity (69.36%) (543.97%) (50.30%)
Return on assets (23.79%) (136.65%) (45.47%)
Return on invested capital (151.17%) 0.00% 0.00%

Growth

Metric CDXS PDSB Biotechnology median
Revenue growth (TTM) 35.89% — 6.78%
EPS growth (last fiscal year) 43.82% 28.16% 29.88%
Revenue growth, 5-year CAGR 0.38% — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CDXS PDSB Biotechnology median
Debt to equity 1.03 (1.21) 0.00
Current ratio 3.06 0.57 4.74
Net debt to EBITDA 1.11 0.50 1.01

Dividend

Metric CDXS PDSB Biotechnology median
Dividend yield — — 0.39%
Payout ratio — — —

Size

Metric CDXS PDSB Biotechnology median
Market cap 109.50m 108.16m 168.63m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack